Invention Grant
- Patent Title: Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use
-
Application No.: US14836330Application Date: 2015-08-26
-
Publication No.: US09657004B2Publication Date: 2017-05-23
- Inventor: Francesco G. Salituro , Jeffrey O. Saunders
- Applicant: AGIOS PHARMACEUTICALS, INC
- Applicant Address: US MA Cambridge
- Assignee: AGIOS PHARMACEUTICALS, INC
- Current Assignee: AGIOS PHARMACEUTICALS, INC
- Current Assignee Address: US MA Cambridge
- Agency: Lando & Anastasi, LLP
- Main IPC: C07D405/14
- IPC: C07D405/14 ; C07D401/04 ; C07D403/04 ; C07D409/04 ; C07D417/04
Abstract:
Compositions comprising compounds that modulate pyruvate kinase M2 (PKM2) are described herein. Also described herein are methods of using the compounds that modulate PKM2 in the treatment of cancer.
Public/Granted literature
- US20160052917A1 PYRUVATE KINASE M2 MODULATORS, THERAPEUTIC COMPOSITIONS AND RELATED METHODS OF USE Public/Granted day:2016-02-25
Information query
